Tech Company Financing Transactions
Stheno Funding Round
Stheno closed a $300 thousand funding round on 5/7/2007. Investors included Georgia Venture Partners and New England Partners.
Transaction Overview
Company Name
Announced On
5/7/2007
Transaction Type
Venture Equity
Amount
$300,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
311 Ferst Dr. NW L1362
Atlanta, GA 30332
USA
Atlanta, GA 30332
USA
Phone
Website
Email Address
Overview
An Atlanta company that is commercializing technology developed at the Georgia Institute of Technology for improving pharmaceutical development and manufacturing
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bill Edens
Chief Scientific Officer
Phillip Gibbs
Browse more venture capital transactions:
Prev: 5/7/2007: Portola Pharmaceuticals venture capital transaction
Next: 5/7/2007: Fortressware venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs